Pelvic Floor Muscle Training (PFMT) in Treatment and Prevention of POP (POP Study)
Effect of Pelvic Floor Muscle Training (PFMT) in Prevention and Treatment of Female Pelvic Organ Prolapse (POP).
2 other identifiers
interventional
168
1 country
1
Brief Summary
Background: The pelvic floor muscles (PFM) are located inside the pelvis, surrounding the urethra, vagina and rectum. They provide structural support for the pelvic organs. Dysfunctional PFM can lead to urine and fecal incontinence, pelvic organ prolapse (POP), sexual problems and chronic pain syndromes. POP increases with age, parity and weakness in the PFM. Symptoms associated with POP are backache, bladder, bowel and sexual dysfunction, and pelvic heaviness. Thus the condition is debilitating and can greatly affect the quality of life, interfering with day-to-day activities and reduce participation in physical activity. The aim of the project: As life expectancy increases, more women may experience POP. Hence it is important to prevent and treat the condition at an early stage. Despite being a common disorder among women, little research has been done on POP. The aim of this study is to evaluate the effect of pelvic floor muscle training (PFMT). PFMT is a non-invasive method with no adverse effects. If there is significant effect, the main goal is to incorporate this method in clinical practice among physiotherapists and medical doctors. If PFM training is effective, more emphasis of PFM training can be put into regular female fitness programs. The prevalence of POP increases with age. Method: This is a single blind randomised controlled trial to evaluate the effect of PFMT on POP. 100 women with POP will be randomised to either training or control group. The training programme will last for six months, training once a week with a physiotherapist in addition to a structured home training programme. A blinded case-control study will also be carried out. 50 women without POP will be matched for age and vaginal deliveries. Before starting the RCT study, a reproducibility study on perineal ultrasound will be carried out in 18 women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2005
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2005
CompletedFirst Submitted
Initial submission to the registry
December 29, 2005
CompletedFirst Posted
Study publicly available on registry
December 30, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2009
CompletedSeptember 21, 2009
September 1, 2009
3.2 years
December 29, 2005
September 18, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (12)
RCT:
Localisation of bladder neck, cervix and rectal ampulla at rest (translabial ultrasound)
Subjective symptoms score (Mouritsen and Larsen 2003, Tegerstedt et al in press, Avery et al 2004)
Ultrasound measurement of changes in muscle morphology: 1. thickness of levator ani
Size of levator hiatus
Levator activity during contraction, coughing and Valsava manoeuvre.
Case control study:
Comparison of background variables and risk factors
Presence of "Benign Hypermobility Joint Syndrome"
Measurement PFM strength
Reproducibility study:
Reproducibility of ultrasound examination of localisation and function of PFM and POP (same measurements as in the RCT)
Secondary Outcomes (3)
RCT study:
Independent variables (muscle function and strength)is vaginal palpation, visual observation of perineum, measurement of muscle strength with Camtech fibreoptic microtransducer connected to a vaginal balloon(Camtech AS, Sandvika, Norway)
* Training diary for registration of adherence
Interventions
Eligibility Criteria
You may qualify if:
- Parous women in Oslo and Akershus
- POP grade 1-3 on POP-Q.
- Age 18-70
You may not qualify if:
- Women with POP-Q grade 0 or 4 and women with cervix elongation
- Women with other disease: radiating back pain, neurological disorders, previous pelvic cancer, psychiatric or other disorders that have an impact on ability to train or the condition (l.o. asthma). Women who is under treatment for cancer or uses muscle relaxants
- Previous POP surgery
- Women who wants to use pessary/ ring during the intervention period and three weeks prior to this
- Pregnant or nursing women, or women planning to become pregnant in the intervention period
- Women with untreated urinary tract infection
- Women who do not understand Norwegian
- Woman planning to be away more than 4 weeks of the intervention period
- Women who cannot contract the PFM
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Norwegian School of Sport Sciences, department of Sports Medicine
Oslo, Oslo County, 0806, Norway
Related Publications (1)
Hoff Braekken I, Majida M, Engh ME, Bo K. Morphological changes after pelvic floor muscle training measured by 3-dimensional ultrasonography: a randomized controlled trial. Obstet Gynecol. 2010 Feb;115(2 Pt 1):317-324. doi: 10.1097/AOG.0b013e3181cbd35f.
PMID: 20093905DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Kari Bø, Prof, Dr.sci
Norwegian School of Sport Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 29, 2005
First Posted
December 30, 2005
Study Start
December 1, 2005
Primary Completion
February 1, 2009
Study Completion
April 1, 2009
Last Updated
September 21, 2009
Record last verified: 2009-09